Post by c-LEcta GmbH

🚀𝐖𝐞 𝐚𝐫𝐞 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐞 𝐥𝐚𝐮𝐧𝐜𝐡 𝐨𝐟 𝐂𝐞𝐥𝐥𝐓𝐫𝐲𝐩𝐚𝐬𝐞! Our new recombinant trypsin-like enzyme of fungal origin was developed specifically for biopharmaceutical customers looking for the highest quality and supply chain security for raw materials. CellTrypase sets a new standard for cell culture-based pharmaceutical processing, offering a superior quality alternative to traditional trypsin solutions. 💎 𝐖𝐡𝐲 𝐜𝐡𝐨𝐨𝐬𝐞 𝐂𝐞𝐥𝐥𝐓𝐫𝐲𝐩𝐚𝐬𝐞? - Exceptional purity, consistency and product quality - GMP-compliant production with full traceability - Efficient cell dissociation while preserving viability and function - Compatible with existing trypsin-based protocols - Available in R&D- and GMP-grades for seamless scale-up 🫶 A huge thank you to our incredible team for making this! Your expertise and dedication are driving innovation in biopharmaceutical manufacturing. 👩‍🔬‍🔬 🔗 Learn more about CellTrypase: https://hubs.ly/Q03MtMcs0 #GMP #CellCultuere #trypsin #Vaccine Kerry Solutions for Pharma

Video Content